arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

American Healthcare REIT, Inc.

AHR

$56.75 ▲ +2.00 (+3.65%) at close

11 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

American Healthcare REIT, Inc. shows mixed fundamentals. Consider comparing against peers in the Real Estate sector before making investment decisions.

Market Cap $9.4B

Dividend Yield 1.76%

Revenue Growth 9.1% ↘

Op. Margin 18.4% ↗

ROIC None

FCF / Share None

Trailing P/E 135.1x

Price / Book 2.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$2.26B

↑ +9.1% —

Net Income Profit after all expenses

$69.81M

↑ +284.6% —

Operating Margin Operating profit as % of sales

18.4%

↑ +4.6% 72th

Health Breakdown

Profitability →

Returns

Dividend History

Dividend / share · sourced from SEC filings

$1.00 Latest / share

+0.0% YoY

-5.1% 10-yr CAGR

FY 2015

$1.60

FY 2016

$2.40

FY 2017

$2.40

FY 2018

$2.40

FY 2019

$0.88

FY 2020

$0.69

FY 2021

$1.60

FY 2022

$1.00

FY 2023

$1.00

FY 2024

$1.00

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Revenue Growth YoY (%)	9.1% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+83%)	24.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+382%)	18.2% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+263%)	25.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+413%)	5.1% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	785.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15604%)	43.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+760%)	153.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2967%)	956.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+19024%)	—	—
EPS Growth YoY (%)	N/M	73.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	12.9% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	-30.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	47.1% Excellent ↑ Excellent Improving Year-over-year change in net income	12.1% Fair Fair Year-over-year change in net income	-70.1% Weak Weak Year-over-year change in net income	N/M	N/M	-124.7% Weak Weak Year-over-year change in net income	N/M	N/M	—	—
FCF Growth YoY (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Revenue CAGR 3Y (%)	17.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	22.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	16.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	127.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	137.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	217.7% Excellent Excellent Compound annual revenue growth over 3 years	237.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	16.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	76.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	81.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	111.5% Excellent Excellent Compound annual revenue growth over 5 years	223.8% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Operating Margin (%) (%)	18.4% Good → Good Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-39%)	17.6% Fair ↓ Fair Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-41%)	18.4% Good ↓ Good Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-39%)	21.4% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-29%)	19.0% Good Good Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-37%)	20.4% Good Good Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-32%)	—	—	—	—	—
Effective Tax Rate (%) (%)	-45.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-5.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.9% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-53.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	3.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-88%)	-1.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-107%)	-4.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-117%)	-5.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-123%)	-4.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-117%)	0.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-99%)	-15.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-162%)	-9.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-140%)	1.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-94%)	-173.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-794%)	—
FCF Margin (%) (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF / Net Income (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Return on Invested Capital (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Capital (%) (%)	7.7% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	8.1% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	6.7% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	6.3% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	4.7% Caution Caution Operating profit relative to total assets Optimal: > 10%	6.7% Caution Caution Operating profit relative to total assets Optimal: > 10%	—	—	—	—	0.0% Weak Weak Operating profit relative to total assets Optimal: > 10%
Return on Common Equity (%) (%)	2.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-74%)	-1.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-121%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-5.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-3.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	0.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-97%)	-3.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	—	—	—	0.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-100%)

⚖️ Is the balance sheet risky? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Interest Coverage (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Debt (USD)	$-114.84M	$-76.70M	$-43.45M	$-65.05M	$-81.60M	$-113.21M	$-15.29M	$-14.39M	$-7.09M	$-2.24M	—
Debt / EBITDA (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Revenue per Share (USD)	$13.61	$15.85	$25.27	$21.46	$22.44	$23.77	—	—	—	—	—
Basic EPS, GAAP (USD)	$0.42	$-0.29	$-1.08	$-1.24	$-0.95	$0.04	—	—	—	—	—
Free Cash Flow per Share (USD) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividend per Share (USD)	$1.00	$1.00	$1.00	$1.60	$0.69	$0.88	$2.40	$2.40	$2.40	$1.60	—
Book Value per Share (USD)	$20.00	$17.31	$19.23	$21.28	$31.57	$19.28	—	—	—	—	—
Tangible Book Value per Share (USD)	$17.06	$14.27	$12.94	$14.17	$22.41	$14.16	—	—	—	—	—
Basic Weighted Avg Shares (shares)	166.06M	130.64M	66.05M	65.81M	50.08M	44.98M	—	—	—	—	—
Dividend Payout Ratio (%)	238.1% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	-344.8% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	-92.6% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	-129.0% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	-72.6% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	2200.0% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—

🏦 How resilient is the balance sheet? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Total Equity (USD)	$3.32B	$2.26B	$1.27B	$1.40B	$1.58B	$866.11M	$590.08M	—	—	—	$200.00K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Sales/Revenue/Turnover (USD)	$2.26B	$2.07B	$1.67B	$1.41B	$1.12B	$1.07B	$120.77M	$84.46M	$33.33M	$3.16M	—
Depreciation Expense (USD)	$187.56M	$179.19M	$182.60M	$167.96M	$133.19M	$98.86M	$45.63M	$32.66M	$13.64M	$1.25M	$0.00
Net Income, GAAP (USD)	$69.81M	$-37.81M	$-71.47M	$-81.30M	$-47.79M	$2.16M	$-18.77M	$-8.35M	$541.00K	$-5.47M	$0.00
Operating Cash Flow (USD)	$294.44M	$176.09M	$98.53M	$147.77M	$17.91M	$219.16M	$39.54M	$15.42M	$12.40M	$-3.62M	$0.00

🏛️ Sector-Specific 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
FFO (approx.) (USD)	$257.37M	$141.38M	$111.14M	$86.66M	$85.40M	$101.02M	$26.86M	$24.30M	$14.18M	$-4.22M	$0.00
FFO per Share (approx.) (USD)	$1.55	$1.08	$1.68	$1.32	$1.71	$2.25	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 45 quarters

American Healthcare REIT, Inc.

Analytical Summary

11-Year Financial Trajectory

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare AHR with peers